ישראל - עברית - Ministry of Health

astellas pharma international b.v., israel - enfortumab vedotin - אבקה להכנת תמיסה מרוכזת לעירוי - enfortumab vedotin 20 mg/vial - enfortumab vedotin

ישראל - עברית - Ministry of Health

astellas pharma international b.v., israel - enfortumab vedotin - אבקה להכנת תמיסה מרוכזת לעירוי - enfortumab vedotin 30 mg/vial - enfortumab vedotin

ישראל - עברית - Ministry of Health

bayer israel ltd - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

ישראל - עברית - Ministry of Health

abbott medical laboratories ltd, israel - omega-3 acid ethyl esters - קפסולות - omega-3 acid ethyl esters 1000 mg - omega-3-triglycerides - omega-3-triglycerides - post myocardial infarction: adjuvant treatment in secondary prevention after myocardial infarction, in addition to other standard therapy (e.g. statins, antiplatelet drugs, betablockers, ace inhibitors). hypertriglyceridaemia: endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient to produce an adequate response: - type iv hypertriglyceridaemia. - type iib/iii hypertriglyceridaemia in combination with statin, when control of triglycerides by statins is insufficient.

ישראל - עברית - Ministry of Health

gsk consumer healthcare, israel ltd - terbinafine hydrochloride - קרם - terbinafine hydrochloride 1 % - terbinafine - terbinafine - fungal infections of the skin caused by dermatophytes such as trichophyton (e.g.t. rubrum t. mentagrophytes t. verrucosum t. violaceum) microsporum canis and epidemophyton floccosum. yeast infections of the skin principally those caused by the genus candida (e.g. candida albicans). pityriasis ( tinea versicolor due to pityrosporum orbiculare (also known as malassezia furfur). for the treatment of plantar-type tinea pedis (moccasin type)

ישראל - עברית - Ministry of Health

gsk consumer healthcare, israel ltd - terbinafine hydrochloride - תמיסה - terbinafine hydrochloride 1 % - terbinafine - terbinafine - fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. t. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum) , microsporum canis and epidermaphyton floccosum.yeast infections of the skin, principally those caused by the genus candida (e.g. candida albicans). pityriasis (tinea) versicolor due to pityrosporum orbiculare (also known as malassezia furfur).

ישראל - עברית - Ministry of Health

bayer israel ltd - clotrimazole - טבליות וגינליות - clotrimazole 200 mg - clotrimazole - clotrimazole - infections in external female genital organs and vagina caused by clotrimazole-sensitive microorganisms such as fungi (candida albicans) and trichomonas.during treatment of vaginitis caused by trichomonas, canesten v must be combined with an oral trichomonacide (e.g metronidazole).

ישראל - עברית - Ministry of Health

bayer israel ltd - clotrimazole - טבליות וגינליות - clotrimazole 200 mg - clotrimazole - clotrimazole - infections in external female genital organs and vagina caused by clotrimazole-sensitive microorganisms such as fungi (candida albicans) and trichomonas.during treatment of vaginitis caused by trichomonas, canesten v must be combined with an oral trichomonacide (e.g metronidazole).

ישראל - עברית - Ministry of Health

bayer israel ltd - testosterone enantate - תמיסה שומנית להזרקה - testosterone enantate 250 mg/ml - testosterone - testosterone - testosterone replacement therapy in male hypogonadism, in cases where testosterone deficiency has been confirmed on the basis of clinical and lboratory evidence.inducing puberty in boys with delayed puberty (pubertas tarda).

ישראל - עברית - Ministry of Health

teva israel ltd - desmopressin acetate - טבליה - desmopressin acetate 0.1 mg - desmopressin - desmopressin - desmopressin teva tablets are indicated for central diabetes insipidus, nocturnal enuresis ( in patients from 5 years of age with normal ability to concentrate the urine) and for symptomatic treatment of nocturia in adults associated with nocturnal polyuria, i.e. nocturnal urine production exceeding bladder capacity. the treatment must be started befor the age of 65.